(#): Preoperative clinical and postoperative pathological TNM stage (Clinical TNM stage before neoadjuvant therapy and postoperative pathological TNM stage was both given for patient number 4) AC: adriamycin+cyclophosphamide; ALND: axillary lymph node dissection; BC: breast cancer; CEF: Cyclophosphamide+Epirubicin+Flourouracil;
DBRi: delayed breast reconstruction with implantation; DC: ductal carcinoma; DCIS: ductal carcinoma insitu; DT: docetaxel; ER: estrogen receptor; F: female; IBR: immediate breast reconstruction; LC: lobular carcinoma; M: male, MRM: modified radical mastectomy; PR: progesterone receptor; SM: simple mastectomy; SLND: sentinel lymph node dissection; SM: segmental mastectomy; RT: radiotherapy; TT: total thyroidectomy; TZM: trastuzumab Table 2.